This year at the 2024 Precision Medicine Forum Berlin, QIAGEN will showcase our barrier-breaking Sample to Insight Oncology solution. Combining targeted DNA and multimodal pan-cancer panels, one of the fastest and cheapest secondary analysis solutions in the market, and industry-leading variant interpretation and reporting software trusted to analyze and interpret over 4 million NGS patient test cases worldwide, our Sample to Insight Oncology solution is revolutionizing precision oncology testing.
Learn more and register here.
